Skip to main content
Veterinary Medicines

Levamisole Hydrochloride 80 % Kela Poeder voor oraal gebruik

Authorised
  • Levamisole hydrochloride

Product identification

Medicine name:
Levamisole Hydrochloride 80 % Kela Poeder voor oraal gebruik
Levamisole Hydrochloride 80 % Kela Pulver zum Einnehmen
Levamisole Hydrochloride 80 % Kela Poudre orale
Active substance:
  • Levamisole hydrochloride
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    800.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Levamisole Hydrochloride 80 % Kela Oral powder Box with 10 bags of 100 g

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V240606
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 16/02/2022
French (PDF)
Published on: 16/02/2022
German (PDF)
Published on: 16/02/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 16/02/2022
French (PDF)
Published on: 16/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."